Carrie Strom Takes the Helm as Chief Executive Officer of Hugel Inc.

Carrie Strom Takes the Helm as CEO of Hugel Inc.

Hugel Inc., the globally recognized medical aesthetics leader, has made headlines with the appointment of Carrie Strom as Chief Executive Officer. This move, revealed on October 13, 2025, is expected to reshape the company's future under Strom's leadership, as the firm aims to solidify its status in the competitive aesthetics market.

Who is Carrie Strom?

Carrie Strom is not new to the pharmaceutical and aesthetics sectors. She spent the last five years as Senior Vice President at AbbVie, where she also held the title of Global President of Allergan Aesthetics. During her tenure, she oversaw a substantial $5 billion portfolio, which included iconic products like Botox Cosmetic and Juvéderm, marketed across more than 50 countries. Strom’s extensive background includes leadership roles at Allergan and Pfizer, where she honed her skills in sales and marketing.

Strom’s rich experience makes her the ideal individual to steer Hugel through its next growth phase. In her words, she expressed her excitement, stating, "I am honored to join Hugel as the CEO and look forward to working alongside the talented and dedicated employees, operating team, and board of directors."

Hugel's Vision for the Future

Since its establishment in 2001, Hugel has emerged as a leader in the medical aesthetics industry, specializing in producing injectables aimed at skin rejuvenation, encompassing botulinum toxin and hyaluronic acid fillers. Moreover, the company has demonstrated a commitment to safety and quality, which resonates with its mission to innovate within the industry.

With Strom at the helm, Hugel is poised for an ambitious transformation that aims to bolster its influence not just in South Korea—where it is the market leader—but also in global markets. Strom’s vision encompasses expanding Hugel's reach while raising service standards for customers and patients worldwide. She aims to leverage the company's strong foundation, rooted in the esteemed Korean beauty standards, to enhance its offerings.

Global Expansion Strategy

Under Strom’s leadership, Hugel is prepared to ramp up its global strategy. The company has already established a footprint in 69 countries with its botulinum toxin products known as Botulax® and Letybo®, alongside its dermal fillers, which are available in 53 nations. Notably, Hugel stands out as the sole South Korean entity with regulatory approvals from the United States, China, and Europe, the three largest markets in the world for aesthetic products.

As Strom transitions into her new role, she will directly oversee Hugel’s executive leadership team while working closely with Daniel Chang, recently appointed head of Hugel Korea. This strategic alliance is expected to enhance the company’s operational efficacy and market responsiveness, ensuring that Hugel remains competitive in an ever-evolving sector.

Industry Leadership and Innovation

The Hugel Board Chairman, Suk Cha, expressed confidence in Strom’s capabilities, stating, “Ms. Strom is a proven enterprise leader who we are confident will lead Hugel to the next level.” As the company accelerates its expansion within the Americas and extends its footprint in other crucial global markets, Strom's expertise will be invaluable.

Hugel has made significant strides over the past two decades, establishing subsidiaries in the USA, Australia, Canada, Taiwan, China, Hong Kong, Singapore, and Thailand. The company’s commitment to comprehensive training programs and dynamic industry forums has solidified its reputation as a forward-thinking leader in the field, paving the way for continued growth.

As the aesthetics industry continues to burgeon, Hugel, under Carrie Strom’s leadership, is set to emerge as a formidable global player, redefining beauty standards and enhancing customer experiences across the globe.